2-38074431-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_000104.4(CYP1B1):c.958G>T(p.Val320Leu) variant causes a missense change. The variant allele was found at a frequency of 0.000128 in 1,613,308 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin ClinVar. Synonymous variant affecting the same amino acid position (i.e. V320V) has been classified as Likely benign.
Frequency
Consequence
NM_000104.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CYP1B1 | NM_000104.4 | c.958G>T | p.Val320Leu | missense_variant | 2/3 | ENST00000610745.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CYP1B1 | ENST00000610745.5 | c.958G>T | p.Val320Leu | missense_variant | 2/3 | 1 | NM_000104.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000131 AC: 20AN: 152176Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000310 AC: 77AN: 248424Hom.: 0 AF XY: 0.000259 AC XY: 35AN XY: 134908
GnomAD4 exome AF: 0.000128 AC: 187AN: 1461014Hom.: 1 Cov.: 31 AF XY: 0.000125 AC XY: 91AN XY: 726810
GnomAD4 genome AF: 0.000131 AC: 20AN: 152294Hom.: 0 Cov.: 33 AF XY: 0.000188 AC XY: 14AN XY: 74454
ClinVar
Submissions by phenotype
Glaucoma 3A Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Oct 23, 2018 | The CYP1B1 c.958G>T (p.Val320Leu) missense variant has been reported in at least four studies, in which it is found in a total of 13 individuals with primary congenital glaucoma, including in two in a compound heterozygous state, and in 11 in a heterozygous state in whom a second variant was not identified (Mashima et al. 2001; Kim et al. 2011; Su & Kee 2012; Do et al. 2016). The p.Val320Leu variant was also present in three additional individuals with primary open angle glaucoma, but the zygosity of the variant was unknown (Gong et al. 2015). The p.Val320Leu variant was present in four of 942 ethnically-matched control subjects and is reported at a frequency of 0.003615 in the East Asian population of the Genome Aggregation Database. Based on the evidence, the p. Val320Leu variant is classified as a variant of unknown significance but suspicious for pathogenicity for primary congenital glaucoma. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
Uncertain significance, criteria provided, single submitter | reference population | Soonchunhyang University Bucheon Hospital, Soonchunhyang University Medical Center | Mar 18, 2016 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Dec 12, 2023 | Variant summary: CYP1B1 c.958G>T (p.Val320Leu) results in a conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00031 in 248424 control chromosomes, predominantly at a frequency of 0.0038 within the East Asian subpopulation in the gnomAD database. This frequency is not significantly higher than estimated for a pathogenic variant in CYP1B1 causing Primary Congenital Glaucoma (0.0038 vs 0.0043), allowing no conclusion about variant significance. c.958G>T has been reported in the literature, primarily in the heterozygous state, in individuals of East Asian ancestry affected with Primary Congenital Glaucoma (e.g. Mashima_2001, Kim_2011, Chen_2014, Do_2016), individuals with primary open-angle glaucoma (Gong_2015), and also in healthy controls (Kim_2011, Gong_2015). The variant was also found in the homozygous state in the unaffected mother of a heterozygous individual with Primary Congenital Glaucoma, providing supporting evidence for a benign role. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 24227805, 26550974, 25527694, 21850185, 11527932, 12598442, 22942166). Four submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance. - |
Glaucoma 3, primary infantile, B;C1856439:Glaucoma 3A;C4310623:Anterior segment dysgenesis 6 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Apr 11, 2022 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | May 17, 2016 | - - |
Congenital glaucoma Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 26, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at